PERCEPTIVE ADVISORS LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$7.9B
Holdings
137
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (137 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | PSTXUSDPOSEIDA THERAPEUTICS INC | 787,745 | $7.5B | 95.07% | |
| 102 | —CATABASIS PHARMACEUTICALS IN | 2,476,924 | $7.2B | 90.46% | |
| 103 | FGENEURFIBROGEN INC | 200,000 | $6.9B | 87.73% | Put |
| 104 | —TCR2 THERAPEUTICS INC | 313,300 | $6.9B | 87.42% | |
| 105 | TARAPROTARA THERAPEUTICS INC | 421,642 | $6.6B | 83.87% | |
| 106 | DRIOEURDARIOHEALTH CORP | 327,869 | $6.3B | 79.79% | |
| 107 | AMWLAMERICAN WELL CORP | 355,000 | $6.2B | 77.92% | |
| 108 | SNDXSYNDAX PHARMACEUTICALS INC | 270,000 | $6.0B | 76.29% | |
| 109 | —VINCERX PHARMA INC | 300,000 | $5.8B | 73.17% | |
| 110 | —BCTG ACQUISITION CORP | 500,000 | $5.6B | 70.26% | |
| 111 | PHRPHREESIA INC | 100,000 | $5.2B | 65.84% | |
| 112 | —HEALTH SCIENCES ACQ CORP 2 | 450,000 | $5.0B | 63.64% | |
| 113 | —LONGVIEW ACQUISITION CORP II | 500,000 | $5.0B | 63.44% | |
| 114 | —CONSONANCE HFW ACQUISITION C | 500,000 | $4.9B | 61.67% | |
| 115 | —DEERFIELD HEALTHCARE TECH AC | 300,000 | $3.9B | 49.66% | |
| 116 | —THERAPEUTICSMD INC | 2,750,000 | $3.7B | 46.57% | |
| 117 | MRUSMERUS N V | 175,000 | $3.7B | 46.19% | |
| 118 | VRAYQVIEWRAY INC | 751,748 | $3.3B | 41.32% | |
| 119 | —TALIS BIOMEDICAL CORP | 250,000 | $3.2B | 40.59% | |
| 120 | —LIFESCI ACQUISITION II CORP | 300,000 | $3.0B | 38.44% | |
| 121 | —SIGILON THERAPEUTICS INC | 125,000 | $2.8B | 35.31% | |
| 122 | RGNXREGENXBIO INC | 69,283 | $2.4B | 29.86% | |
| 123 | GRTXGALERA THERAPEUTICS INC | 254,664 | $2.2B | 28.38% | |
| 124 | —MOTUS GI HLDGS INC | 1,800,542 | $2.1B | 26.16% | |
| 125 | 1D5APLX PHARMA INC | 222,180 | $2.0B | 25.35% | |
| 126 | —CM LIFE SCIENCES INC | 127,000 | $1.9B | 23.90% | |
| 127 | BFLYWBUTTERFLY NETWORK INC | 233,333 | $1.5B | 19.02% | |
| 128 | RACEFERRARI N V | 6,200 | $1.3B | 16.40% | |
| 129 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 139,890 | $1.2B | 15.64% | |
| 130 | —VINCERX PHARMA INC | 300,000 | $1.2B | 15.32% | |
| 131 | —SIERRA ONCOLOGY INC | 66,655 | $1.1B | 14.51% | |
| 132 | —SC HEALTH CORP | 500,000 | $945.0M | 11.94% | |
| 133 | PHVSPHARVARIS N V | 27,000 | $755.0M | 9.54% | |
| 134 | —CEREVEL THERAPEUTICS HLDNG I | 133,066 | $573.0M | 7.24% | |
| 135 | CVM1EURCEL-SCI CORP | 33,700 | $513.0M | 6.48% | |
| 136 | SANASANA BIOTECHNOLOGY INC | 10,000 | $335.0M | 4.23% | |
| 137 | —DEERFIELD HEALTHCARE TECH AC | 20,000 | $242.0M | 3.06% |
PreviousPage 2 of 2